These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 17689349)

  • 1. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using words: the harm reduction conception of drug use and drug users.
    Stafford N
    Int J Drug Policy; 2007 Mar; 18(2):88-91. PubMed ID: 17689350
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug policy, harm and human rights: a rationalist approach.
    Stevens A
    Int J Drug Policy; 2011 May; 22(3):233-8. PubMed ID: 21481578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction and the global drug control regime: contemporary problems and future prospects.
    Bewley-Taylor DR
    Drug Alcohol Rev; 2004 Dec; 23(4):483-9. PubMed ID: 15763753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harm reduction ethics: a promising basis for drug policy.
    Miller P
    Drug Alcohol Rev; 2005 Nov; 24(6):553-4. PubMed ID: 16361213
    [No Abstract]   [Full Text] [Related]  

  • 6. Harm reduction--an ethical imperative.
    Van Beek I
    Addiction; 2009 Mar; 104(3):342-3; discussion 345-6. PubMed ID: 19207339
    [No Abstract]   [Full Text] [Related]  

  • 7. Moral frameworks, ethical engagement and harm reduction: commentary on 'Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics' by C. L. Fry, C. Treloar & L. Maher.
    Keane H
    Drug Alcohol Rev; 2005 Nov; 24(6):551-2. PubMed ID: 16361212
    [No Abstract]   [Full Text] [Related]  

  • 8. Applied communitarian ethics for harm reduction: promoting a dialogue within the field.
    Fry C; Treloar C; Maher L
    Drug Alcohol Rev; 2007 Sep; 26(5):553-5. PubMed ID: 17701519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications.
    Moore D; Fraser S
    Soc Sci Med; 2006 Jun; 62(12):3035-47. PubMed ID: 16413645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ushering in another harm reduction era? Discursive authenticity, drug policy and research.
    Hathaway AD
    Drug Alcohol Rev; 2005 Nov; 24(6):549-50. PubMed ID: 16361211
    [No Abstract]   [Full Text] [Related]  

  • 11. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding post 9/11 drug control policy and politics in Central Asia.
    Latypov A
    Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From harm reduction to human rights: bringing liberalism back into drug reform debates.
    Hathaway AD
    Drug Alcohol Rev; 2002 Dec; 21(4):397-404. PubMed ID: 12537711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of pleasure in harm reduction: perspectives from the history of sexuality.
    Race K
    Int J Drug Policy; 2008 Oct; 19(5):417-23. PubMed ID: 17904347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The issue of harm reduction in Polish legislation concerning drug addiction. A comparative study].
    Sobeyko J
    Ann Acad Med Stetin; 2008; 54(2):119-31. PubMed ID: 19374242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction is now the mainstream global drug policy.
    Wodak A
    Addiction; 2009 Mar; 104(3):343-5; discussion 345-6. PubMed ID: 19207340
    [No Abstract]   [Full Text] [Related]  

  • 17. Normalization and harm reduction: research avenues and policy agendas.
    Erickson PG; Hathaway AD
    Int J Drug Policy; 2010 Mar; 21(2):137-9. PubMed ID: 20022234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction coming of age: A summary of the '18th International Conference on the Reduction of Drug Related Harm'-Warsaw, Poland: 13-17 May 2007.
    Moskalewicz J; Barrett D; Bujalski M; Dabrowska K; Klingemann H; Klingemann J; Malczewski A; Struzik M
    Int J Drug Policy; 2007 Dec; 18(6):503-8. PubMed ID: 18061432
    [No Abstract]   [Full Text] [Related]  

  • 19. If supply-oriented drug policy is broken, can harm reduction help fix it? Melding disciplines and methods to advance international drug-control policy.
    Greenfield VA; Paoli L
    Int J Drug Policy; 2012 Jan; 23(1):6-15. PubMed ID: 21689918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilemmas in harm minimization.
    Weatherburn D
    Addiction; 2009 Mar; 104(3):335-9. PubMed ID: 18855811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.